Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Greggs (GRG) by Ben McPoland in The Motley Fool
- Sell Inspired (INSE) by Steve Moore in ShareProphets
- Neutral Schroders (SDR) by JP Morgan
- Sell Jaywing (JWNG) by Steve Moore in ShareProphets
- Sell Jubilee Metals Group (JLP) by Tom Winnifrith in ShareProphets
- Sell Jubilee Metals Group (JLP) by Steve Moore in ShareProphets
- Sell Tribe Technology (TRYB) by Steve Moore in ShareProphets
- Outperform Hollywood Bowl Group (BOWL) by RBC Capital
- Buy JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
- Hold Legal & General Group (LGEN) by Harvey Jones in The Motley Fool
- Sell Gelion (GELN) by Steve Moore in ShareProphets
- Buy GSK (GSK) by Harvey Jones in The Motley Fool
- Neutral Synthomer (SYNT) by UBS
- Neutral Carvana Co Class A (0A79) by UBS
- Equal Weight United Utilities Group (UU.) by Barclays
- Overweight Workspace Group (WKP) by Barclays
- Equal Weight Safestore Holdings (SAFE) by Barclays
- Equal Weight Severn Trent (SVT) by Barclays
- Overweight Pennon Group (PNN) by Barclays
- Overweight Land Securities Group (LAND) by Barclays
Roquefort Therapeutics (ROQ) Share Price
Health Care Sector
NOTE: This is based on 0 open tips for Roquefort Therapeutics (ROQ)
| Latest Bid : 3.80p | Latest Ask : 4.10p |
| High Today : 4.08p | Low Today : 3.80p |
| This Years High : 9.25p | This Years Low : 3.35p |
| Volume : 520,577 | MKT Cap : £5.33M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Roquefort Therapeutics (ROQ) Overview
We established Roquefort Therapeutics plc to acquire businesses focused on early-stage opportunities in the medical biotechnology sector with the aim of generating optimal returns for both the target businesses and our shareholders. The investment strategy of the Company is to provide Shareholders with an attractive total return achievedprimarily through capital appreciation. The Directors believe that there are numerous investment opportunities
within both private and public businesses in the medical biotech sector in the United Kingdom, Continental
Europe and Australia.
Roquefort Therapeutics (ROQ) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 3.80p | Latest Ask : 4.10p |
| High Today : 4.08p | Low Today : 3.80p |
| This Years High : 9.25p | This Years Low : 3.35p |
| Volume : 520,577 | MKT Cap : £5.33M |
Roquefort Therapeutics Overview
We established Roquefort Therapeutics plc to acquire businesses focused on early-stage opportunities in the medical biotechnology sector with the aim of generating optimal returns for both the target businesses and our shareholders. The investment strategy of the Company is to provide Shareholders with an attractive total return achievedprimarily through capital appreciation. The Directors believe that there are numerous investment opportunities
within both private and public businesses in the medical biotech sector in the United Kingdom, Continental
Europe and Australia.
NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.